Valiant Laboratories Share Price

NSE
110
+1.04 (1.83%)
VALIANTLAB • 20 Jun, 2025 | 03:29 PM
BUY
The current prices are delayed, login or Open Demat Account for live prices.
Valiant Laboratories Stock Performance
Today’s Low - High
106.10
110.00
106.10
110.00
52 Week Low - High
75.20
157.49
75.20
157.49

Open

106.91

Prev. Close

108.96

Total Traded Value

7.78 L

View details of Market Depth
Valiant Laboratories Fundamental

Market Cap (in crs)

475.78

Face Value

10

Turnover (in lacs)

7.78

Key Metrics
Qtr Change %
30.47% Fall from 52W High
29
Dividend yield 1yr %
0

Valiant Laboratories Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Valiant Laboratories Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
57.79 Cr
35.23 Cr
21.48 Cr
18.88 Cr
30.59 Cr

Valiant Laboratories Yearly Revenue

Mar 2025Mar 2024Mar 2023
138.82 Cr
191.74 Cr
338.77 Cr

Valiant Laboratories Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
0.7 Cr
2.35 Cr
-4.74 Cr
-0.51 Cr
-1.24 Cr

Valiant Laboratories Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023
-2.2 Cr
0.32 Cr
29 Cr
Valiant Laboratories Result Highlights
  • Valiant Laboratories Ltd reported a 10.1% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 64.8%.

  • Its expenses for the quarter were up by 1.3% QoQ and down 56.4% YoY.

  • The net profit decreased 152.8% QoQ and decreased 112.4% YoY.

  • The earnings per share (EPS) of Valiant Laboratories Ltd declined at 0.3 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Valiant Laboratories shareholding Pattern

Promoter
74.9%
Foreign Institutions
0.6%
Public
24.4%
Promoter
74.9%
Public
25.1%
Promoter
74.9%
Public
25.1%
Promoter
74.9%
Foreign Institutions
1.9%
Public
23.2%
Promoter
74.9%
Foreign Institutions
3.5%
Public
21.6%
Promoter
74.9%
Foreign Institutions
7.1%
Domestic Institutions
0.4%
Public
17.5%

Valiant Laboratories Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
110
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
111.50
10Day EMA
111.80
12Day EMA
111.50
20Day EMA
109.90
26Day EMA
108.60
50Day EMA
104.70
100Day EMA
103.10
200Day EMA
110.30
5Day SMA
112.20
10Day SMA
113.80
20Day SMA
109.40
30Day SMA
107.20
50Day SMA
103.80
100Day SMA
97.30
150Day SMA
102.60
200Day SMA
106.40
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
4540 Rs
7655 Rs
Week Rs
15217 Rs
19521 Rs
Month Rs
63846 Rs
64824 Rs
Resistance & Support
108.53
Pivot
Resistance
First Resistance
110.97
Second Resistance
112.43
Third Resistance
114.87
Support
First Support
107.07
Second support
104.63
Third Support
103.17
Relative Strength Index
51.86
Money Flow Index
84.04
MACD
2.97
MACD Signal
3.52
Average True Range
5.29
Average Directional Index
29.12
Rate of Change (21)
4.76
Rate of Change (125)
-1.93

Valiant Laboratories Latest News

28 MAY 2025 | Wednesday

Valiant Laboratories Ltd - 543998 - Compliances-Reg.24(A)-Annual Secretarial Compliance

22 MAY 2025 | Thursday

Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Newspaper Publication

20 MAY 2025 | Tuesday

Valiant Laboratories Ltd - 543998 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

View More

Valiant Laboratories Company background

Founded in: 2021
Managing director: Santosh S. Vora
Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of M/s. Bharat Chemicals through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name Valiant Laboratories Limited through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or parahydroxyacetanilide C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the firstline therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products. Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an inhouse RD infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL). In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.The Company has come out with a Public Issue of issuing upto 11,556,000 Equity Shares through fresh issue.

As of 20 Jun, 2025, Valiant Laboratories share price is ₹109.5. The stock opened at ₹106.9 and had closed at ₹109 the previous day. During today’s trading session, Valiant Laboratories share price moved between ₹106.10 and ₹110.00, with an average price for the day of ₹108.05. Over the last 52 weeks, the stock has recorded a low of ₹75.20 and a high of ₹157.49. In terms of performance, Valiant Laboratories share price has declined by 5.9% over the past six months and has declined by 22.83% over the last year.

Read More

Valiant Laboratories FAQs

Valiant Laboratories share price is ₹110 in NSE and ₹109.45 in BSE as on 20/6/2025.

Valiant Laboratories share price in the past 1-year return was -22.97. The Valiant Laboratories share hit a 1-year low of Rs. 75.2 and a 1-year high of Rs. 157.49.

The market cap of Valiant Laboratories is Rs. 475.78 Cr. as of 20/6/2025.

The PE ratios of Valiant Laboratories is 0 as of 20/6/2025.

The PB ratios of Valiant Laboratories is 2.02 as of 20/6/2025

You can easily buy Valiant Laboratories shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Valiant Laboratories stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -